<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-111906</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Sulfasalazine-Induced Linear Immunoglobulin A Bullous Dermatosis with DRESS</dc:title>
<dc:description xml:lang="en">Linear immunoglobulin (Ig) A dermatosis is an immune-mediated bullous disease characterized by linear deposits of IgA along the basal membrane. While usually idiopathic, it can occasionally be induced by drug exposure. We report the case of a 60-year-old woman with rheumatoid arthritis being treated with sulfasalazine who developed linear IgA dermatosis and drug rash with eosinophilia and systemic symptoms (DRESS). The dermatosis and associated symptoms resolved following withdrawal of the drug and treatment with systemic corticosteroids for 2 months. This is the first report of sulfasalazine-induced linear IgA dermatosis in association with DRESS and we believe that sulfasalazine should be added to the list of drugs that can cause linear IgA dermatosis (AU)</dc:description>
<dc:creator>Soler, E</dc:creator>
<dc:creator>Borrego, L</dc:creator>
<dc:creator>Hernández, N</dc:creator>
<dc:creator>Hernández, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La dermatosis inducida por inmunoglobulina A (IgA) lineal es una enfermedad ampollosa mediada inmunológicamente que se define por presentar un depósito lineal de IgA a lo largo de la membrana basal. Habitualmente es idiopática y ocasionalmente se asocia con algunos fármacos. Describimos el caso de una mujer de 60 años con artritis reumatoide en tratamiento con sulfasalazina, que desarrolló un cuadro de dermatosis IgA lineal con clínica de drug-rash with eosinophilia and systemic symptoms (DRESS) el cual respondió al suspender el fármaco causal más tratamiento con corticoides sistémicos durante 2 meses. Este es el primer caso descrito de dermatosis IgA lineal con clínica de DRESS relacionado con la sulfasalazina. Creemos que es importante tener en cuenta esta asociación para poder incluir la sulfasalazina en el listado de fármacos que pueden producir dermatosis IgA lineal por fármacos (AU)</dc:description>
<dc:source>Actas Dermosifiliogr;104(4): 343-346, mayo 2013. ilus, tab</dc:source>
<dc:identifier>ibc-111906</dc:identifier>
<dc:title xml:lang="es">Dermatosis ampollosa inducida por inmunoglobulina A lineal con clínica de síndrome DRESS por sulfasalazina</dc:title>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22202^s22020</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d12835^s22079</dc:subject>
<dc:subject>^d13252^s22016</dc:subject>
<dc:subject>^d12835^s22044</dc:subject>
<dc:subject>^d13252^s22032</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d13252^s22036</dc:subject>
<dc:subject>^d13252^s22057</dc:subject>
<dc:subject>^d13252^s22012</dc:subject>
<dc:subject>^d12835^s22073</dc:subject>
<dc:subject>^d1178^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201305</dc:date>
</metadata>
</record>
</ibecs-document>
